Options Surge on M&A Shock and Earnings Fever
A blockbuster after-hours deal sent options traders scrambling Monday. Vertex Pharmaceuticals agreed to buy Crinetics Pharmaceuticals for $85 per share in cash. CRNX stock doubled on the news. The deal is a sharp jolt…